A multicentre cross-sectional descriptive study evaluating the cardiovascular risk profile of preoperatively identified patients with hypertension
| Autor: | J Roos, E Cloete, JG Davids, Brian Rayner, B M Biccard, Robert A. Dyer, F Roodt, R. Van Zyl, T Pretorius, C Pfister, V Koller, Zahnne Fullerton, S Govender, M Nejthardt, M Flint, E Chiu, Justiaan Swanevelder |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male medicine.medical_specialty Blood Pressure South Africa Internal medicine medicine Prevalence Humans Mass Screening Prediabetes Risk factor Renal Insufficiency Chronic Adverse effect Aged Metabolic Syndrome business.industry General Medicine Perioperative Middle Aged medicine.disease Blood pressure Cross-Sectional Studies Cardiovascular Diseases Heart Disease Risk Factors Hypertension Preoperative Period Population study Female Metabolic syndrome business Kidney disease |
| Zdroj: | SAMJ: South African Medical Journal, Volume: 111, Issue: 1, Pages: 74-79, Published: JAN 2021 South African Medical Journal; Vol. 111 No. 1 (2021); 74-79 |
| ISSN: | 2078-5135 |
| Popis: | Background. The prevalence of hypertension in adults in South Africa (SA) is 35%. Hypertension is the most important modifiable risk factor for cardiovascular (CV) and chronic kidney disease (CKD) in sub-Saharan Africa. However, 49% of people are unaware of their blood pressure status. Screening for hypertension prior to surgery provides a unique opportunity to diagnose and treat affected individuals. Furthermore, assessing overall CV risk identifies patients at highest risk for complications, and improves the utilisation of scarce resources. Objectives. To evaluate the CV risk profile of hypertensive patients in the adult population of the Western Cape Province presenting for elective non-cardiac, non-obstetric surgery. Methods. This report documents the CV risk profile of patients recruited to the HASS-2 study (Hypertension and Surgery Study 2), which was undertaken in seven Western Cape hospitals. Patients were screened for hypertension and pharmacological treatment was initiated or adjusted in patients with stages 1 and 2 disease. Stage 3 patients were referred to a physician. In the present substudy, patients with stages 1 and 2 hypertension were assessed for associated CV risk factors, the presence of target organ damage, and documented CV or kidney disease; they received an overall risk stratification according to the 2018 European Society of Cardiology and the European Society of Hypertension Guidelines. Results. Sixty-one patients with stage 1 and 12 with stage 2 hypertension were analysed. Established CV disease was present in 13.7% of the study population, and CKD (eGFR |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|